🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to test the utility of PET/MRI in diagnosis an...
Status
Unknown
Location
Steffen Husby
Start Date
2018-10-18
Trial ID
NCT03640637
This study is to evaluate and directly compare the technical success, tissu...
Status
Completed
Location
Center for Interventional Endoscopy
Start Date
2019-07-25
Trial ID
NCT04003766
Treatments Being Tested
Nelfinavir will increase the efficacy of Cisplatin based chemo- radiation t...
Status
Completed
Location
University of Miami
Start Date
2012-01
Trial ID
NCT01485731
Rapid urease test (RUT) is the most commonly used biopsy-based method to di...
Status
Completed
Location
Far Eastern Memorial Hospital
Start Date
2010-08
Trial ID
NCT01282853
Treatments Being Tested
Study to confirm the sensitivity of the C\^13-UBT using the new test meal f...
Status
Withdrawn
Location
CHI de créteil
Start Date
2020-11
Trial ID
NCT04294823
Treatments Being Tested
Cervical cancer as well cervical preneoplastic abnormalities (CIN2+) are ca...
Status
Completed
Location
Universidad de Antioquia
Start Date
2011-01
Trial ID
NCT02067468
Treatments Being Tested
50 patients with pancreatic mass will undergo endoscopic ultrasound-guided ...
Status
Completed
Location
Hospital das Clinicas da FMUSP
Start Date
2015-04-27
Trial ID
NCT03111368
Treatments Being Tested
Rationale: Worldwide, the aging population is increasing. Aging is associat...
Status
Completed
Location
Maastricht University
Start Date
2024-08-20
Trial ID
NCT06553794
Treatments Being Tested
The goal of this clinical trial is to evaluate the safety and efficacy of E...
Status
Unknown
Location
Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
Start Date
2023-02-01
Trial ID
NCT05662553
Treatments Being Tested
In this Phase II study a dose of 2.8 mg (eight 0.35 mg siG12D-LODERs) will ...
Status
Unknown
Location
Hackensack Meridian Health
Start Date
2018-03-07
Trial ID
NCT01676259
Treatments Being Tested